Sodelglitazar

Sodelglitazar

SCHEMBL29801577

Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3F)nc2C)ccc1OC(C)(C)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARAPPARDPPARG

The experimentally established mechanism targets of Sodelglitazar. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PPARD known ✓ Q03181 19/20 0.59
PPARA known ✓ Q07869 17/20 0.59
PPARG known ✓ P37231 8/20 0.59
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 1/20 0.54
ALOX15 P16050 1/20 0.54
KMT2A Q03164 1/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sodelglitazar SCHEMBL4822839 1.00 PPARD (0.59) PPARDPPARAPPARGMEN1ALDH1A1
Sodelglitazar SCHEMBL29378834 1.00 PPARD (0.59) PPARDPPARAPPARGMEN1ALDH1A1
SCHEMBL6838544 0.91 PPARD (0.55) PPARDPPARAPPARGMEN1ALDH1A1
SCHEMBL6236397 0.87 PPARD (0.78) PPARDPPARAPPARGMEN1ALDH1A1
SCHEMBL6385692 0.83 PPARD (0.53) PPARDPPARAPPARGMEN1ALDH1A1
SCHEMBL4812687 0.80 PPARD (0.69) PPARDPPARAPPARG
SCHEMBL4808599 0.78 PPARD (0.66) PPARDPPARAPPARGMEN1ALDH1A1
SCHEMBL4827386 0.78 PPARD (0.49) PPARDPPARAPPARG
SCHEMBL4806719 0.78 PPARD (0.65) PPARDPPARAPPARGMEN1ALDH1A1
SCHEMBL12267474 0.78 PPARA (0.49) PPARDPPARAPPARGMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031124-A1 USE OF A PPAR-DELTA AGONIST IN THE TREATMENT OF KIDNEY DISEASE Reneo Pharmaceuticals, Inc. (US) 2022-07-27 EP claimed
EP-4031124-A1 USE OF A PPAR-DELTA AGONIST IN THE TREATMENT OF KIDNEY DISEASE Reneo Pharmaceuticals, Inc. (US) 2022-07-27 EP disclosed